Entinostat, nivolumab and ipilimumab for women with advanced HER2-negative breast cancer: a phase Ib trialEvanthia T. Roussos Torres, Roisín M. Connolly, Won Jin Ho et al.|Nature Cancer|2024Cited by 49
Targeting OCT2 with Duloxetine to Prevent Oxaliplatin-induced Peripheral NeurotoxicityMahesh R. Nepal, Alex Sparreboom, Muhammad Erfan Uddin et al.|Cancer Research Communications|2022Cited by 12